6 completed, 1 recruiting. 2 Not applicable, 2 Phase 4, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Recruiting 1 |
| Phase 4 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow titanium dioxide: new trials by email Literature Review of titanium dioxide trials Research Report on titanium dioxide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Racial Congruence, "Likes", and Food Images in Social Media Ads on Adolescents' Caloric Intake - Study 3 Black-Food, White-Food, Black-Non Food - Calorie Consumption | Not applicable | Recruiting | NYU Langone Health | 480 | 2025-04-30 | 2026-06-10 |
| Antibacterial Effect and Clinical Performance of Chitosan Modified Glass Ionomer Glass Ionomer, Chitosan Low Molecular Weight (20-200 Mpa.S), Chlorhexidine Diacetate - Reversible Pulpitis, Pulpitis | Phase 3 | Completed | Ain Shams University | 65 | 2019-01-15 | 2021-01-12 |
| Therapeutic Efficacy of Phytosterols on Metabolic Syndrome Phytosterols, Titanium Dioxide - Metabolic Syndrome x | Not applicable | Completed | Universidad de los Andes, Chile | 220 | 2018-01-08 | 2020-03-17 |
| Effect of MVX (Titanium Dioxide) on the Microbial Colonization of Surfaces in an Intensive Care Unit MVX (titanium dioxide) - Environmental Contamination | Completed | drs. B. de Jong | 35 | 2015-03-01 | 2016-08-29 | |
| Ultraviolet and UV-Visible Light Photoprotection for the Treatment of Melasma 290-400 nm sunscreen, 290-800 nm sunscreen - Melasma | Phase 4 | Completed | Universidad Autonoma de San Luis Potosà | 68 | 2012-09-01 | 2014-12-02 |
| Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF40 Cream Titanium dioxide - Sunburn | Phase 4 | Completed | Loreal USA | 26 | 2009-12-01 | 2011-06-14 |
| Evaluation of the Protection Activity of Microfine Titanium Dioxide (Ti02), Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With Idiopathic Solar Urticaria (SU) Titanium dioxide (Ti02) microfine 12.15% alone (formula RV3131A-MV1209), Ti02 pigmentary 3% alone (formula RV3131A-MV1211), bisoctrizole 10% alone (formula RV3131A-MV1237) - Idiopathic Solar Urticaria | Phase 2 | Completed | Orfagen | 16 | 2007-09-01 | 2017-12-22 |
Dental Caries (1) · Melanosis (1) · Metabolic Syndrome (1) · Pulpitis (1) · Sunburn (1)
Ain Shams University (1) · Loreal USA (1) · NYU Langone Health (1) · Orfagen (1) · Universidad Autonoma de San Luis Potosà (1) · Universidad de los Andes, Chile (1) · drs. B. de Jong (1)
United States (2) · Canada (1) · Chile (1) · Egypt (1) · Mexico (1) · Netherlands (1) · United Kingdom (1)
Arthur van Zanten, MD, PhD (1) · Bertha Torres-Alvarez, MD (1) · Diana Hernandez-Blanco, MD (1) · James Ferguson, Pr (1) · Juan P Castanedo-Cazares, MD (1) · Marie A. Bragg, PhD (1) · Mariem Wassel, Assistant professor (1) · Noha Kabil, Professor (1) · Patrick Dupuy, Dr (1)
PMID 26079388, PMID 27766712, PMID 28190299, PMID 32785036
R01CA248441 (1)